(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE](/api/compound/7tIrgw7fnuf.png?ph=true&h=300&w=458 "(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | 7tIrgw7fnuf |
|---|---|
| InChI | InChI=1S/C21H32N4O/c1-4-7-14-25(15-8-5-2)20(26)21(17-12-10-9-11-13-17)16-18(21)19(6-3)23-24-22/h9-13,18-19H,4-8,14-16H2,1-3H3/t18-,19-,21+/m0/s1 |
| InChIKey | MHVRKRQPKABADV-IRFCIJBXSA-N |
| Mol Weight | 356.5 g/mol |
| Molecular Formula | C21H32N4O |
| Exact Mass | 356.257612 g/mol |
| Enantiomer InChIKey | MHVRKRQPKABADV-SBHAEUEKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIPROPYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
DIETHYL(2-HYDROXYETHYL)METHYLAMMONIUM IODIDE, 4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Derivatives Modified at the Carbamoyl Moiety As a New Class of NMDA Receptor Antagonists | Bioorganic & Medicinal Chemistry | 2002 |